Revance Therapeutics Merger $17M Settlement — Oregon Residents
This settlement specifically covers Oregon residents. Check your eligibility and file your claim before the deadline.
Oregon Eligibility
The settlement includes all persons and entities who purchased or otherwise acquired Revance securities between Feb. 29, 2024, and Feb. 6, 2025, inclusive, including common stock (CUSIP 761330109; ticker RVNC) and 1.75% fixed coupon convertible senior unsecured notes (CUSIP 761330AB5).
About This Settlement
Investors who bought Revance securities between Feb. 29, 2024, and Feb. 6, 2025, may be eligible to claim a cash payment from a class action settlement.
Who Is Eligible?
The settlement includes all persons and entities who purchased or otherwise acquired Revance securities between Feb. 29, 2024, and Feb. 6, 2025, inclusive, including common stock (CUSIP 761330109; ticker RVNC) and 1.75% fixed coupon convertible senior unsecured notes (CUSIP 761330AB5).
Claim Details
- Payout
- $17,000,000
- Deadline
- July 13, 2026 (61 days)
- Proof Needed
- Yes — see claim form
- Category
- Financial
More Oregon Settlements
Frequently Asked Questions — Oregon Residents
Settlement data sourced from court records and official settlement administrators. Last verified: May 13, 2026.